Euroimmun Medizinische Labordiagnostika Ag

Mayo Foundation for Medical Education and Research

Stefanie Hahn

Lars Komorowski

Yvonne Denno

Ramona Miske

Madeleine Scharf

Christian Probst

Vanda A Lennon

Winfried Stoecker

Thomas J Kryzer

Andrew McKeon

Sean J Pittock

Christiane Radzimski

Inga-Madeleine Dettmann

Stephanie Kade

Josephe A Honorat

Mandy Unger

Farid Benkhadra

George Trendelenburg

Winfried STÖCKER

A method for diagnosing a disease can include detecting, in a sample from a patient, an autoantibody binding to Septin-7. A polypeptide comprising Septin-7 or a variant thereof can be used for the diagnosis of a disease. Preferably, the polypeptide is used to detect an autoantibody binding to Septin-7 in a sample. A kit is useful for the diagnosis of a disease. The kit may include a polypeptide that includes Septin-7 or a variant thereof or a medical device that includes a polypeptide that includes Septin-7 or a variant thereof and an autoantibody to Septin-7.

Autoantibodies to Septin-7 and diagnosis of neurological disease

A method is used for diagnosing a disease by detecting in a sample with antibodies from a patient an autoantibody binding to DAGLA.

Diagnosis of a neuroautoimmune disease

A method for diagnosing a disease by detecting an autoantibody that binds to flotillin1 and/or flotillin2 in a sample, a polypeptide comprising flotillin1 and/or flotillin2 or a variant thereof, which may be immobilized, a method of treating a disease by applying to a subject the polypeptide that binds to an autoantibody, an autoantibody binding to flotillin1 and/or flotillin2, a method for isolating the autoantibody, a pharmaceutical composition, a medical device and test kit comprising the polypeptide, are provided. A method for detecting the presence of an autoantibody is also provided.

Diagnosis of a neuroautoimmune disease comprising measuring autoantibodies to flotillin1 and/or flotillin2

Growing community of inventors

Reinfeld, Germany

Stefanie Hahn